FDA Unanimously Votes in Favor of New Hepatitis C Drug

Oct 25, 2013 6:37 PM

WASHINGTON (AP) - Food and Drug Administration advisers have unanimously voted in favor of a highly anticipated hepatitis C drug from Gilead Sciences that holds promise for millions of Americans infected with the liver-destroying virus.

All 15 members of the FDA's panel of virus experts voted to recommend approval of Gilead's pill to treat several forms of hepatitis C that account for most cases in the U.S. About 3 million people in the U.S. have hepatitis C, a blood-borne disease that causes liver damage.

It is blamed for 15,000 deaths annually


Most Popular